Business Description
L&K Biomed Co Ltd
ISIN : KR7156100000
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | -6.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.35 | |||||
Beneish M-Score | -1.69 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.5 | |||||
3-Year EBITDA Growth Rate | 26.6 | |||||
3-Year EPS without NRI Growth Rate | -2.2 | |||||
3-Year FCF Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | -2.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.73 | |||||
9-Day RSI | 54.6 | |||||
14-Day RSI | 54.53 | |||||
6-1 Month Momentum % | 21.9 | |||||
12-1 Month Momentum % | 52.62 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.95 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.56 | |||||
Days Inventory | 1564.14 | |||||
Days Sales Outstanding | 106.17 | |||||
Days Payable | 237.95 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.1 | |||||
Shareholder Yield % | 3.14 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.16 | |||||
Operating Margin % | -21.7 | |||||
Net Margin % | -6.24 | |||||
FCF Margin % | -11.6 | |||||
ROE % | -8.07 | |||||
ROA % | -3.28 | |||||
ROIC % | -11.23 | |||||
ROC (Joel Greenblatt) % | -18.49 | |||||
ROCE % | -17.2 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.64 | |||||
PB Ratio | 4.92 | |||||
Price-to-Tangible-Book | 5.04 | |||||
EV-to-EBIT | -39.13 | |||||
EV-to-EBITDA | -82.02 | |||||
EV-to-Revenue | 5.84 | |||||
EV-to-FCF | -49.87 | |||||
Price-to-Net-Current-Asset-Value | 10.23 | |||||
Earnings Yield (Greenblatt) % | -2.55 | |||||
FCF Yield % | -1.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
L&K Biomed Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 29,904.806 | ||
EPS (TTM) (â‚©) | -129.26 | ||
Beta | 1.61 | ||
Volatility % | 94.49 | ||
14-Day RSI | 54.53 | ||
14-Day ATR (â‚©) | 407.171548 | ||
20-Day SMA (â‚©) | 8544.5 | ||
12-1 Month Momentum % | 52.62 | ||
52-Week Range (â‚©) | 4287.115121 - 12620 | ||
Shares Outstanding (Mil) | 19.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
L&K Biomed Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
L&K Biomed Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
L&K Biomed Co Ltd Frequently Asked Questions
What is L&K Biomed Co Ltd(XKRX:156100)'s stock price today?
When is next earnings date of L&K Biomed Co Ltd(XKRX:156100)?
Does L&K Biomed Co Ltd(XKRX:156100) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |